Clas Rehnberg
Clas Rehnberg
Verifierad e-postadress på ki.se
TitelCiteras avÅr
Cost of depression in Europe.
P Sobocki, B Jönsson, J Angst, C Rehnberg
Journal of Mental Health Policy and Economics, 2006
6182006
Costs and quality of life associated with osteoporosis-related fractures in Sweden
F Borgström, N Zethraeus, O Johnell, L Lidgren, S Ponzer, O Svensson, ...
Osteoporosis international 17 (5), 637-650, 2006
3542006
Health related quality of life in different states of breast cancer
M Lidgren, N Wilking, B Jönsson, C Rehnberg
Quality of life research 16 (6), 1073-1081, 2007
1722007
At what hip fracture risk is it cost-effective to treat?
F Borgström, O Johnell, JA Kanis, B Jönsson, C Rehnberg
Osteoporosis international 17 (10), 1459-1471, 2006
1312006
The impact of China's retail drug price control policy on hospital expenditures: a case study in two Shandong hospitals
Q Meng, G Cheng, L Silver, X Sun, C Rehnberg, G Tomson
Health Policy and Planning 20 (3), 185-196, 2005
1162005
Internal markets and health care efficiency: a multiple‐output stochastic frontier analysis
UG Gerdtham, M Löthgren, M Tambour, C Rehnberg
Health economics 8 (2), 151-164, 1999
1101999
The impact of internal markets on health care efficiency: evidence from health care reforms in Sweden
UG Gerdtham, C Rehnberg, M Tambour
Applied Economics 31 (8), 935-945, 1999
1011999
Cost of affective disorders in Europe
P Andlin‐Sobocki, HU Wittchen
European Journal of Neurology 12, 34-38, 2005
852005
Cost-effectiveness of HER2 testing and 1-year adjuvant trastuzumab therapy for early breast cancer
M Lidgren, B Jönsson, C Rehnberg, N Willking, J Bergh
Annals of oncology 19 (3), 487-495, 2007
842007
How are individual-level social capital and poverty associated with health equity? A study from two Chinese cities
X Sun, C Rehnberg, Q Meng
International Journal for Equity in Health 8 (1), 2, 2009
732009
Deteriorating health status in Stockholm 1998–2002: results from repeated population surveys using the EQ-5D
K Burström, M Johannesson, C Rehnberg
Quality of Life Research 16 (9), 1547-1553, 2007
732007
Drug policy in China: pharmaceutical distribution in rural areas
H Dong, L Bogg, C Rehnberg, V Diwan
Social science & medicine 48 (6), 777-786, 1999
711999
Resource use and costs associated with different states of breast cancer
M Lidgren, N Wilking, B Jönsson, C Rehnberg
International journal of technology assessment in health care 23 (2), 223-231, 2007
682007
Measuring cost efficiency in the Nordic Hospitals—a cross-sectional comparison of public hospitals in 2002
M Linna, U Häkkinen, M Peltola, J Magnussen, KS Anthun, S Kittelsen, ...
Health care management science 13 (4), 346-357, 2010
612010
Health care performance comparison using a disease-based approach: the EuroHOPE project
U Häkkinen, T Iversen, M Peltola, TT Seppälä, A Malmivaara, É Belicza, ...
Health Policy 112 (1-2), 100-109, 2013
592013
A description of outpatient drug use in rural China: evidence of differences due to insurance coverage
H Dong, L Bogg, K Wang, C Rehnberg, V Diwan
The International Journal of Health Planning and Management 14 (1), 41-56, 1999
581999
Cost-effectiveness of HER2 testing and trastuzumab therapy for metastatic breast cancer
M Lidgren, N Wilking, B Jönsson, C Rehnberg
Acta Oncologica 47 (6), 1018-1028, 2008
572008
The impact of urban health insurance reform on hospital charges: a case study from two cities in China
Q Meng, C Rehnberg, N Zhuang, Y Bian, G Tomson, S Tang
Health Policy 68 (2), 197-209, 2004
562004
Association between health insurance and antibiotics prescribing in four counties in rural China
H Dong, L Bogg, C Rehnberg, V Diwan
Health Policy 48 (1), 29-45, 1999
551999
Economic impact of adverse drug events–a retrospective population-based cohort study of 4970 adults
H Gyllensten, KM Hakkarainen, S Hägg, A Carlsten, M Petzold, ...
PLoS One 9 (3), e92061, 2014
502014
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20